Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Tucker

Showing results (161-170 of 466) with videos related to

Pageof 47
Sort By:
Fertility and Sterility|May 12, 2004
Monitoring plasma concentrations to individualize treatment with clomiphene citrateAmin Rostami-Hodjegan, Martin S Lennard, Geoffrey T Tucker, et al.
Biomedical Chromatography : BMC|May 15, 2007
Validation and application of capillary electrophoresis for the analysis of lidocaine in a skin tape stripping studyZ Chik, A Johnston, A T Tucker, et al.
Clinical Pharmacology and Therapeutics|October 1, 1986
Metoprolol and debrisoquin metabolism in Nigerians: lack of evidence for polymorphic oxidationA O Iyun, M S Lennard, G T Tucker, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 10, 2009
Correcting endogenous concentrations of testosterone influences bioequivalence and shows the superiority of TDS(R)-testosterone versus Androgel(R)Z Chik, A Johnston, A T Tucker, et al.
British Journal of Clinical Pharmacology|November 1, 1986
Polymorphic drug oxidation: pharmacokinetic basis and comparison of experimental indicesP R Jackson, G T Tucker, M S Lennard, et al.
Carcinogenesis|December 1, 1994
Interindividual variation in the isomerization of 4-hydroxytamoxifen by human liver microsomes: involvement of cytochromes P450M L Williams, M S Lennard, I J Martin, et al.
Progress in Clinical and Biological Research|January 1, 1986
The detection of polymorphic drug oxidation--some theoretical and practical aspectsG T Tucker, P R Jackson, M S Lennard, et al.
British Journal of Clinical Pharmacology|February 15, 2007
The use of mechanistic DM-PK-PD modelling to assess the power of pharmacogenetic studies -CYP2C9 and warfarin as an exampleGemma L Dickinson, Martin S Lennard, Geoffrey T Tucker, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 20, 2004
Predicting the clearance of CYP2C9 substratesKaren Rowland Yeo, Eleanor M Howgate, Geoffrey T Tucker, et al.
Peerj|April 15, 2021
Age constraint for the Moreno Hill Formation (Zuni Basin) by CA-TIMS and LA-ICP-MS detrital zircon geochronologyCharl D Cilliers, Ryan T Tucker, James L Crowley, et al.
Pageof 47

Showing results (161-170 of 466) with videos related to

Sort By:
Pageof 47
Fertility and Sterility|May 12, 2004
Monitoring plasma concentrations to individualize treatment with clomiphene citrateAmin Rostami-Hodjegan, Martin S Lennard, Geoffrey T Tucker, et al.
Biomedical Chromatography : BMC|May 15, 2007
Validation and application of capillary electrophoresis for the analysis of lidocaine in a skin tape stripping studyZ Chik, A Johnston, A T Tucker, et al.
Clinical Pharmacology and Therapeutics|October 1, 1986
Metoprolol and debrisoquin metabolism in Nigerians: lack of evidence for polymorphic oxidationA O Iyun, M S Lennard, G T Tucker, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 10, 2009
Correcting endogenous concentrations of testosterone influences bioequivalence and shows the superiority of TDS(R)-testosterone versus Androgel(R)Z Chik, A Johnston, A T Tucker, et al.
British Journal of Clinical Pharmacology|November 1, 1986
Polymorphic drug oxidation: pharmacokinetic basis and comparison of experimental indicesP R Jackson, G T Tucker, M S Lennard, et al.
Carcinogenesis|December 1, 1994
Interindividual variation in the isomerization of 4-hydroxytamoxifen by human liver microsomes: involvement of cytochromes P450M L Williams, M S Lennard, I J Martin, et al.
Progress in Clinical and Biological Research|January 1, 1986
The detection of polymorphic drug oxidation--some theoretical and practical aspectsG T Tucker, P R Jackson, M S Lennard, et al.
British Journal of Clinical Pharmacology|February 15, 2007
The use of mechanistic DM-PK-PD modelling to assess the power of pharmacogenetic studies -CYP2C9 and warfarin as an exampleGemma L Dickinson, Martin S Lennard, Geoffrey T Tucker, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 20, 2004
Predicting the clearance of CYP2C9 substratesKaren Rowland Yeo, Eleanor M Howgate, Geoffrey T Tucker, et al.
Peerj|April 15, 2021
Age constraint for the Moreno Hill Formation (Zuni Basin) by CA-TIMS and LA-ICP-MS detrital zircon geochronologyCharl D Cilliers, Ryan T Tucker, James L Crowley, et al.
Pageof 47